Richard L. Gabriel, Director at Predictive Oncology Inc. (POAI), bought 2,000 shares at $0.46 ($920) on 2019-09-05, disclosed to the SEC on 2019-09-06.
Open-market purchase of $920 POAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| POAI | BUY | 2019-08-26 | $2K | — | Filing → |
| AIPT | BUY | 2018-12-12 | $1K | — | Filing → |
| AIPT | BUY | 2018-11-29 | $2K | — | Filing → |